ArticleFrontiers in oncology2022

Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control.

Kyoung-Ho Pyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.